2018
DOI: 10.1007/s10495-018-1450-2
|View full text |Cite
|
Sign up to set email alerts
|

Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways

Abstract: Epirubicin is an anthracycline and is widely used in tumor treatment, but has toxic and undesirable side effects on wide range of cells and hematopoietic stem cells (HSC). Osteoblasts play important roles in bone development and in supporting HSC differentiation and maturation. It remains unknown whether epirubicin-induced bone loss and hematological toxicity are associated with its effect on osteoblasts. In primary osteoblast cell cultures, epirubicin inhibited cell growth and decreased mineralization. Moreov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 29 publications
0
14
0
1
Order By: Relevance
“…In the present study, McAb blocked extracellular 15-kDa-ALR without influencing 23-kDa-ALR, which may be the reason for the inconsistent results with previous studies. Therefore, epirubicin, a traditional chemotherapy drug used to induce apoptosis (40), was employed in the present study. When the injury factor was present, apoptosis was increased as expected.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, McAb blocked extracellular 15-kDa-ALR without influencing 23-kDa-ALR, which may be the reason for the inconsistent results with previous studies. Therefore, epirubicin, a traditional chemotherapy drug used to induce apoptosis (40), was employed in the present study. When the injury factor was present, apoptosis was increased as expected.…”
Section: Discussionmentioning
confidence: 99%
“…There are two pathways in caspase-dependent cell apoptosis: the death receptor-mediated exogenous pathway and the mitochondrial-mediated endogenous pathway [ 27 ]. The common induction of apoptosis involves one of the apoptotic modes [ 28 , 29 , 30 ]; studies on triggering endogenous and exogenous apoptosis are widely available [ 31 , 32 , 33 ]. Exogenous pathways are caspase cascades triggered by the binding of death receptor Fas or TFN-α with its extracellular ligands.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have found that epirubicin can increase the expression of FasL and FADD, the extrinsic apoptotic pathway‐related factors in primary cultured osteosarcoma cells. These factors then upregulate the content of ROS, Bax, and Cyt‐c in cells, inducing apoptosis through the mitochondrial‐dependent pathway . Berbamine can also lead to the loss of MMP in human hepatocellular carcinoma cells (SMMC‐7721).…”
Section: Discussionmentioning
confidence: 99%